Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Swiss Caps To Provide Insulin Pill for Oramed Trials | Contract Pharma

What are you searching for?

Sign in
Breaking News

Swiss Caps To Provide Insulin Pill for Oramed Trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Oramed Pharmaceuticals, Inc. has signed a manufacturing agreement with Swiss Caps AG for the manufacture of gel capsules for its Phase I trials. In lieu of a cash payment, Swiss Caps offered a straight equity exchange for its services and will be paid in shares. This followed a due diligence process and an in-depth review of Oramed’s oral delivery technology, according to a Swiis Caps statement.

“This type of agreement means cooperation with Swiss Caps rather than just out-service of the production line. Swiss Caps brings to the table skills and knowledge that goes beyond the direct execution of our formula and we are looking forward to seeing the benefits from our group effort,” stated Nadav Kidron, Oramed’s chief executive officer.

This agreement is only for the manufacturing of the product for proof of efficacy in clinical trials. Should Swiss Caps manufacture Oramed’s drug product for commercial purposes, the contract will be renegotiated.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics